* To replay the media content and watch again, please refresh your screen

In this interactive patient case study developed by international experts, you'll follow two different von Willebrand disease (VWD) patient cases, make educated decisions about their care, and see how your answers impact the patients' trajectories.

After taking part, you'll understand the occurrence and impact of VWD in the emergency care setting, how to treat and manage VWD in daily clinical practice, and how to implement international VWD guidelines.

Take the interactive cases or follow the link to take the accredited e-learning to count towards your CME credit.

 

Looking to take the interactive patient case study on your phone?  Coming soon – the smartphone version. 

In the meantime, enjoy the course on desktop and tablet.

 

Clinical Takeaways

  • Refer to the haematologist for diagnostic testing if you suspect a bleeding disorder in your patient, as coagulation screening tests may be normal in some cases

  • Consult a haematologist before performing any invasive procedures, planned or acute, and in case of trauma in a patient with von Willebrand disease

  • Patients with VWD may need a haemostatic treatment plan in place before you proceed

Jan Blatný, MD, PhD, is Consultant Haematologist at the Department of Paediatric Haematology and Biochemistry, Centre for Thrombosis and Haemostasis and the Director of the Haemophilia Comprehensive Care Centre of University Hospital in Brno, Czech Republic. He is also an Associate Professor of Paediatrics at Masaryk University in Brno, Czech Republic. His research interests encompass paediatric haematology, thrombosis and haemostasis, and life-threatening bleeding. He is a member of the Working Party on population PK of the ISTH SSC Subcommittee on Factor VIII and IX and Rare Bleeding Disorders. In addition to ISTH, Dr Blatný is a member of numerous national and international haematology organizations. He serves on the steering committee and is a paediatric coordinator of the Czech National Haemophilia Programme, Vice-president and a member of Executive Committee of EAHAD, member of MAG (Medical advisory group) of EHC, a reviewer for several haematology journals, and is on the editorial board for an official journal of Czech Haematology society. Dr Blatný’s publication credits are 9 book chapters and over 100 articles published in peer-reviewed journals

Assoc. Prof. Jan Blatný has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Novo Nordisk, Pfizer, Roche, Sobi and Takeda. 

Dr Mazzeffi is a cardiothoracic anesthesiologist and intensive care physician. He is currently Vice Chair for Faculty Affairs and Development in the department of anesthesiology at University of Virginia Health. He is an active clinical researcher with an interest in hemostasis, viscoelastic coagulation testing, extracorporeal membrane oxygenation, and acquired Von Willebrand Syndrome in patients on mechanical circulatory support. He is an active teacher and mentor for medical students, anesthesiology residents and fellows.

 

Dr Michael A Mazzeffi has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Hemosonics Corporation and Octapharma. 

Programme summary
  • clock Duration 30 MIN
  • clock Language(s) flag
Take the e-learning now
Share this programme
This educational programme is supported by an Independent Educational Grant from Takeda
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
HEMOSTASIS CONNECT

HEMOSTASIS CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Pfizer, Takeda, Viatris and Pentapharm.

Meet the experts Independent IME approved

Other programmes of interest

podcast Podcast

Episode

2

of 2

episode
Hemostasis and bleeding disorders 
Thrombophilia testing: Who to test and when?

Episode 2 - Medical experts discuss the controversies around thrombophilia testing, review the current ASH guidelines and share their views on best practice

Experts
Prof. Saskia Middeldorp, Prof. Jean Connors
  • download Downloadable
    Resources
  • clock MIN
  • calendar May 2024

Educational programme supported by an Independent Educational Grant from Pentapharm
podcast Podcast

Episode

1

of 2

episode
Hemostasis and bleeding disorders 
Thrombophilia: Clinical overview and impact on patients

Episode 1 - Experts discuss the main causes and symptoms of thrombophilia, and potential implications for the patient

Experts
Prof. Cedric Hermans, Prof. Sabine Eichinger
  • download Downloadable
    Resources
  • clock MIN
  • calendar Feb 2024

Educational programme supported by an Independent Educational Grant from Pentapharm.
video Video
Hemostasis and bleeding disorders 
MOVE Haemophilia 2023

Implementing international guidelines and best practices for hemophilia in clinical practice

Experts
Prof. Ana Boban, Dr Christoph Königs, Prof. Jan Astermark, Prof. Pratima Chowdary, Dr Steven Kitchen, Dr Sebastien Lobet
  • download Downloadable
    Resources
  • clock 15 MIN
  • calendar Dec 2023

Educational programme supported by an Independent Educational Grant from Sobi.
podcast Podcast
Rare diseases Hemostasis and bleeding disorders 
Rare diseases: gene therapy and gene-modified cell therapies

Current role, potential and the example of hemophilia

Experts
Prof. Cedric Hermans, Prof. Miguel Escobar
  • download Downloadable
    Resources
  • clock MIN
  • calendar Dec 2023

Educational programme supported by an Independent Educational Grant from American Society of Gene + Cell Therapy and Pfizer.
podcast Podcast

Episode

4

of 4

episode
Hemostasis and bleeding disorders 
Perioperative thromboprophylaxis revisited

Minimising the risk of thrombosis in surgical patients

Experts
Prof. Dimitrios Tsakiris, Prof. Daniel Bolliger
  • download Downloadable
    Resources
  • clock MIN
  • calendar Nov 2023

Educational programme supported by an Independent Educational Grant from Viatris.
podcast Podcast

Episode

3

of 4

episode
Hemostasis and bleeding disorders 
VTE: What is the optimal duration of antithrombotic treatment?

Part 3 of a 4-part series on thrombosis

Experts
Prof. Dimitrios Tsakiris, Prof. Jerzy Windyga
Endorsed by
Fundacja Trombofilia i Zakrzepica
  • download Downloadable
    Resources
  • clock MIN
  • calendar Oct 2023

Educational programme supported by an Independent Educational Grant from Viatris.